Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Karras

Showing results (171-180 of 236) with videos related to

Pageof 24
Sort By:
Journal of Autoimmunity|August 20, 2022
Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathyClémentine Rousselin, Zahir Amoura, Stanislas Faguer, et al.
European Journal of Internal Medicine|February 5, 2026
Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysisValentin Maisons, Antoine Hankard, Alojzija Hočevar, et al.
Presse Medicale (Paris, France : 1983)|October 8, 2013
Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitidesPierre Charles, Boris Bienvenu, Bernard Bonnotte, et al.
American Journal of Hematology|May 4, 2023
Prognosis and long-term outcomes in type I cryoglobulinemia: A multicenter study of 168 patientsAmine Ghembaza, Gonçalo Boleto, Marin Bommelaer, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2011
Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosisOlivia Boyer, Geneviève Benoit, Olivier Gribouval, et al.
Journal of Autoimmunity|April 29, 2020
Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group RegistryYann Nguyen, Christian Pagnoux, Alexandre Karras, et al.
Rheumatology (Oxford, England)|February 2, 2022
Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?Pauline Morel, Alexandre Karras, Raphaël Porcher, et al.
British Journal of Haematology|July 27, 2019
Survival and specific outcome of sickle cell disease patients after renal transplantationChristel Gérardin, Anissa Moktefi, Cécile Couchoud, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 15, 2023
C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological FeaturesMelchior Chabannes, Marion Rabant, Carine El Sissy, et al.
JAMA|December 7, 2017
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical TrialFrank Bridoux, Pierre-Louis Carron, Brigitte Pegourie, et al.
Pageof 24

Showing results (171-180 of 236) with videos related to

Sort By:
Pageof 24
Journal of Autoimmunity|August 20, 2022
Renal and vascular outcomes in patients with isolated antiphospholipid syndrome nephropathyClémentine Rousselin, Zahir Amoura, Stanislas Faguer, et al.
European Journal of Internal Medicine|February 5, 2026
Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysisValentin Maisons, Antoine Hankard, Alojzija Hočevar, et al.
Presse Medicale (Paris, France : 1983)|October 8, 2013
Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitidesPierre Charles, Boris Bienvenu, Bernard Bonnotte, et al.
American Journal of Hematology|May 4, 2023
Prognosis and long-term outcomes in type I cryoglobulinemia: A multicenter study of 168 patientsAmine Ghembaza, Gonçalo Boleto, Marin Bommelaer, et al.
Journal of the American Society of Nephrology : JASN|January 25, 2011
Mutations in INF2 are a major cause of autosomal dominant focal segmental glomerulosclerosisOlivia Boyer, Geneviève Benoit, Olivier Gribouval, et al.
Journal of Autoimmunity|April 29, 2020
Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group RegistryYann Nguyen, Christian Pagnoux, Alexandre Karras, et al.
Rheumatology (Oxford, England)|February 2, 2022
Management of severe renal disease in anti-neutrophil-cytoplasmic-antibody-associated vasculitis: the place of rituximab and plasma exchange?Pauline Morel, Alexandre Karras, Raphaël Porcher, et al.
British Journal of Haematology|July 27, 2019
Survival and specific outcome of sickle cell disease patients after renal transplantationChristel Gérardin, Anissa Moktefi, Cécile Couchoud, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 15, 2023
C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological FeaturesMelchior Chabannes, Marion Rabant, Carine El Sissy, et al.
JAMA|December 7, 2017
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical TrialFrank Bridoux, Pierre-Louis Carron, Brigitte Pegourie, et al.
Pageof 24